Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 July 2025
- Conf. stmt due
- 16 July 2027
- Last conf. stmt
- 2 July 2026
Myricx Pharma Limited
- Incorporated
- 3 July 2019 (7 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Bertrand Richard Rene BugnonJohan Mikael Olof KahlstroemSandeep Gupta
- Owned by
- Novartis AG
- Accounts type
- Small
- Region
- Greater London
- Address
- 125 Wood StreetLondonEC2V 7AW
Officers 4 active
Officer details are public data from the Companies House register.
Cullen, Richard Samuel
Secretary · Appointed 28 August 2026
Bugnon, Bertrand Richard Rene
Director · Appointed 28 August 2026
Swiss
Born March 1967 (59)
Kahlstroem, Johan Mikael Olof
Director · Appointed 28 August 2026
Swedish
Born July 1980 (46)
Gupta, Sandeep
Director · Appointed 28 August 2026
Indian
Born June 1982 (44)
Officer history (15 former)
28 August 2026
Resigned Bauer, Michael Karl as Director
28 August 2026
Appointed Kahlstroem, Johan Mikael Olof as Director
28 August 2026
Appointed Gupta, Sandeep as Director
28 August 2026
Resigned Punwani, Jayson, Dr as Director
28 August 2026
28 August 2026
28 August 2026
28 August 2026
28 August 2026
Appointed Bugnon, Bertrand Richard Rene as Director
28 August 2026
Appointed Cullen, Richard Samuel as Secretary
28 August 2026
Resigned Rawat, Mohit as Director
10 November 2025
Resigned Conroy, Lucille, Dr as Director
10 November 2025
Appointed Punwani, Jayson, Dr as Director
3 October 2025
Appointed Rawat, Mohit as Director
10 September 2025
Resigned Carr, Robin Arthur Ellis, Dr as Director
11 February 2025
27 January 2025
Resigned Paoletti, Paolo, Dr as Director
30 November 2024
Resigned Hawthorne, Grant as Secretary
20 September 2024
Appointed Paoletti, Paolo, Dr as Director
28 June 2024
Appointed Bauer, Michael Karl as Director
28 June 2024
Resigned Tate, Edward William, Professor as Director
28 June 2024
Appointed Conroy, Lucille, Dr as Director
19 June 2024
Resigned Brake, Rachael as Director
10 November 2023
10 November 2023
19 April 2023
Resigned Thompson, Henry Stephen Grammer, Dr as Director
19 April 2023
11 October 2022
Appointed Carr, Robin Arthur Ellis, Dr as Director
23 February 2021
Appointed Brake, Rachael as Director
20 December 2019
Appointed Hawthorne, Grant as Secretary
30 October 2019
Appointed Thompson, Henry Stephen Grammer, Dr as Director
30 October 2019
3 July 2019
3 July 2019
Appointed Tate, Edward William, Professor as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Novartis AG
Corporate entity · Notified 28 August 2026
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Aktiengesellschaft (Ag)
Reg. no. Che-103.867.266
Former controllers (1)
30 October 2019
Ceased Edward William Tate — Owns 50–75% of shares
Financials
Figures from 2023 accounts. Newer accounts, made up to 31 July 2025, are filed but not read yet. See them on Companies House
- Net Assets
- (£3,684,834)
- Cash
- £985,106
- Employees
- 8
- Debt Ratio
- 325%
- Current Ratio
- 0.3x
Trend
Net Assets
Balance sheet detail
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Fixed Assets | £47,482 | £64,852 | £82,026 | £3,292 |
| Current Assets | £1,592,685 | £2,194,623 | £1,490,361 | £1,893,961 |
| Cash | £985,106 | £1,526,888 | £884,571 | £1,570,643 |
| Creditors (< 1 year) | £5,313,831 | £276,188 | £136,654 | £143,143 |
| Creditors (> 1 year) | £0 | £3,162,247 | ||
| Net Current Assets | (£3,721,146) | £1,918,435 | £1,353,707 | £1,750,818 |
| Net Assets | (£3,684,834) | (£1,195,085) | £1,415,313 | £1,753,501 |
| Shareholder Funds | (£3,684,834) | (£1,195,085) | £1,415,313 | £1,753,501 |
Filings 105
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 25 September 2026 | Registered office address changed | |||
| 15 September 2026 | Current accounting period extended | |||
| 11 September 2026 | Change of share class name or designation | |||
| 11 September 2026 | Particulars of variation of rights attached to shares | |||
| 9 September 2026 | Memorandum and Articles of Association |
Some other companies at this address
Other companies in this industry
Newcastle Upon Tyne
Edinburgh
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →